Work

Supplemental Table and Figures from Poly (ADP-Ribose) Polymerase Inhibitor Hypersensitivity in Aggressive Myeloproliferative Neoplasms

Year: 2023

Type: supplementary-materials

Abstract: Table S1: Primers for Methylation Analysis. Figure S1: Sensitivity of erythroid and myeloid progenitors to veliparib. Figure S2: Reproducibility of colony forming assays. Figure S3: Veliparib IC50 as a function of BRCA1 Promotor Methylation.

DOI: 10.1158/1078-0432.22456695

Authors: Keith W. Pratz, Brian D. Koh, Anand G. Patel, Karen S. Flatten, Weijie Poh, James G. Herman, Robert Dilley, Maria I. Harrell, B. Douglas Smith, Judith E. Karp, Elizabeth M. Swisher, Michael A. McDevitt, Scott H. Kaufmann

Language: English

Topic: PARP inhibition in cancer therapy

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4362395869

Cites:

Cited by:

Related to: 10